Today is World Parkinson’s Day.
Parkinson’s disease is a brain disease affecting around 145,000 people in the UK and at first, it mainly causes problems with movement.
Around a third of people with Parkinson’s eventually develop dementia.
Read here: https://t.co/cuciK9S94J
We are very proud of Lauren's achievements so far, she is on course to be a fantastic scientist and role model for students. Please consider donating to this worthwhile cause. You can read Lauren's remarkable journey below.
This week is Brain Awareness Week. On Friday we will host several short talks from researchers in the Dept on different fields of Brain research. @AislingNoone2@AimoneFerri and @JO_omos12 will be presenting, followed by an address by @ASNeuro
https://t.co/dxdezXJPDe
It is an honour and pleasure to work with this group of inspiring and collaborative postgrad, postdoc, technical, administrative and academic colleagues
@AnatNeuroUCC#IWD2024@UCC
https://t.co/7n5gv0o5Iz
We are excited to launch our study on the impacts on hormonal fluctuations in women with #Parkinson’s. This #PPI -led research, with @RichelleFlan, will track symptoms across menstrual cycle and aid better treatment and outcomes for women. https://t.co/pZGiCcafCk
World-first study on hormonal impact on women with #Parkinsons disease.
Professor Aideen Sullivan @ASNeuro said this #PPI-led research with @RichelleFlan will track symptoms across menstrual cycle and aid better treatment and outcomes for women
https://t.co/0QNtyvScIB
👏Congratulations @Brian__Curtin , MA Coaching & Positive Psychology student who is part of the @roinnslainte SciComm Collective - scientists promoting healthy habits.
👀Check them out on Tiktok - Brian's include https://t.co/PH7MWm9m0O and https://t.co/UQ9fkMbISY
UCC Futures - Future Ageing & Brain Science is a focused collaborative research effort to improve outcomes and quality-of-life for all individuals and for our society. @UCC@UCCResearch
Now up - Joan Omosefe Osayande from @UCC is presenting on alterations in the gut microbiota induced by AAV mediated overexpression of alpha synuclein in a 'brain-first' model of early stage Parkinson's
#neuroscience#NSI2023